Project 170462

Molecular basis for Central Core Disease and RyR1-related myopathies

170462

Molecular basis for Central Core Disease and RyR1-related myopathies

$925,458
Project Information
Study Type: Other Social_Historical_Analysis
Therapeutic Area: Oncology
Research Theme: Biomedical
Disease Area: cancer genomics and personalized medicine
Institution & Funding
Principal Investigator(s): Maclennan, David H
Co-Investigator(s): Gramolini, Anthony O
Institution: University of Toronto
CIHR Institute: Genetics
Program: Operating Grant
Peer Review Committee: Cell Physiology
Competition Year: 2008
Term: 5 yrs 0 mth
Abstract Summary

Muscle contraction is triggered by the release of calcium into muscle cells from a storage compartment inside the cells, referred to as the sarcoplasmic reticulum; relaxation is initiated by return of calcium to the storage compartment. Thus every bodily movement and every heartbeat is dependent on calcium fluxes. Calcium release channels are responsible for releasing calcium from the storage compartment to bring about muscle contraction. Two human diseases, malignant hyperthermia, a toxic response to anesthetics, and central core disease, causing muscle weakness, are caused by mutations in the skeletal muscle form of the calcium release channel. In recent work, Dr. MacLennan and his group have developed a mouse line in which the calcium release channel is mutated to an inactive form. When both copies of the mutant gene are present, the embryonic mouse displays a block in development; when only one copy is present, the mouse lives, but displays symptoms of muscle disease that are consistent with central core disease. Both of these mouse models of disease are interesting. The block in development is caused by the lack of calcium signals that direct proper development in mice, but these signals are not defined. Dr. Maclennan's group propose to identify these signals. The mouse with central core disease offers the opportunity for understanding how this and other muscle diseases develop and how intervention might ameliorate the effects of muscle diseases.

Research Characteristics

This project includes the following research characteristics:

Health Technology Assessment
Implementation Science
Policy Evaluation
Health System Integration
Barrier Identification
Industry Partnership
Regulatory Pathway
Ethics Focus
Social Determinants
Health Equity
Knowledge Translation Focus
Equity Considerations
Personalized Medicine
Study Justification

"analyze the introduction of genomic techniques and concepts in cancer medicine from historical and sociological perspectives"

Novelty Statement

"investigating the rearrangement of relations between laboratory and clinic in translational research"

Methodology Innovation

historical and sociological analysis of genomic medicine implementation

Keywords
Animal Models Biochemistry Central Core Disease Genetic Disease Ryanodine Receptor Skeletal Muscle